Cargando…
Goserelin acetate before transurethral resection of moderately enlarged benign prostatic hyperplasia: Prospective randomised-controlled clinical trial
OBJECTIVE: To evaluate the impact of a luteinising hormone-releasing hormone (LHRH) agonist, goserelin acetate (GA), on surgical blood loss during transurethral resection of the prostate (TURP), as well as its histopathological effect on prostatic microvessel density (MVD). PATIENTS AND METHODS: Pat...
Autores principales: | Abo El-Enen, Mohamed, Tawfik, Ahmed, El-Abd, Ahmed S., Ragab, Maged, El-Abd, Sherin, Elrashidy, Mohamed, Elmashad, Nehal, Rasheed, Mohamed, El-Abd, Shawky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767797/ https://www.ncbi.nlm.nih.gov/pubmed/26966595 http://dx.doi.org/10.1016/j.aju.2015.09.007 |
Ejemplares similares
-
Transurethral bipolar plasmakinetic vapo-enucleation of the prostate: Is it safe for patients on chronic oral anticoagulants and/or platelet aggregation inhibitors?
por: El-Shaer, Waleed, et al.
Publicado: (2017) -
Intraprostatic injection of botulinum toxin-A in patients with refractory chronic pelvic pain syndrome: The transurethral vs. transrectal approach
por: El-enen, Mohamed A., et al.
Publicado: (2015) -
Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
por: Agamia, Naglaa F., et al.
Publicado: (2016) -
Day care bipolar transurethral resection vs photoselective vaporisation under sedoanalgesia: A prospective, randomised study of the management of benign prostatic hyperplasia
por: Sood, Rajeev, et al.
Publicado: (2017) -
Immediate and late management of iatrogenic ureteric injuries: 28 years of experience
por: El Abd, Ahmed S., et al.
Publicado: (2015)